Are The "Magnificent Seven" Stocks Still Worth Buying?

The key market issue is not whether the mega-cap AI complex is “good,” but whether the bundle is mispriced as a single factor trade. Dispersion is doing the damage: the winners have durable operating leverage from AI capex, while the laggard is losing optionality in a way that can compress the entire basket multiple because passive flows do not discriminate well until earnings season forces them to.

Second-order, the best risk/reward may be away from the names that already own the narrative and toward the picks-and-shovels where revenue can still compound at a much faster rate off a smaller base. That said, those smaller AI names will be more fragile if cloud spend or semiconductor ordering normalizes, so the trade is really a beta expression on continued AI infrastructure buildout, not a blanket endorsement of “AI” as a theme.

The contrarian point is that net income optics are becoming less useful in the megacaps when investment marks and financial engineering can flatter headline earnings. Markets will likely keep paying for operating income durability, but only until there is evidence of capex fatigue or margin plateauing; that is the clean falsifier for the bullish AI leadership case over the next 1-3 months. Over 6-18 months, if the autonomy thesis fails to monetize, the weakest valuation support in the group remains the most vulnerable to further multiple compression.